ID: ALA4088068

Max Phase: Preclinical

Molecular Formula: C33H31N7O5

Molecular Weight: 605.66

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C=CC(=O)Nc1cc(Nc2ncc3c(n2)N(C)C(=O)N(c2cc(NC(=O)c4ccc5c(c4)OCCO5)ccc2C)C3)ccc1C

Standard InChI:  InChI=1S/C33H31N7O5/c1-5-29(41)37-25-15-23(9-6-19(25)2)36-32-34-17-22-18-40(33(43)39(4)30(22)38-32)26-16-24(10-7-20(26)3)35-31(42)21-8-11-27-28(14-21)45-13-12-44-27/h5-11,14-17H,1,12-13,18H2,2-4H3,(H,35,42)(H,37,41)(H,34,36,38)

Standard InChI Key:  XDMQCUFOFSCUBC-UHFFFAOYSA-N

Associated Targets(Human)

Tyrosine-protein kinase BMX 1995 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

BaF3 4657 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 605.66Molecular Weight (Monoisotopic): 605.2387AlogP: 5.56#Rotatable Bonds: 7
Polar Surface Area: 138.02Molecular Species: NEUTRALHBA: 8HBD: 3
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 3#RO5 Violations (Lipinski): 3
CX Acidic pKa: 13.11CX Basic pKa: 1.69CX LogP: 5.01CX LogD: 5.01
Aromatic Rings: 4Heavy Atoms: 45QED Weighted: 0.23Np Likeness Score: -1.28

References

1. Liang X, Lv F, Wang B, Yu K, Wu H, Qi Z, Jiang Z, Chen C, Wang A, Miao W, Wang W, Hu Z, Liu J, Liu X, Zhao Z, Wang L, Zhang S, Ye Z, Wang C, Ren T, Wang Y, Liu Q, Liu J..  (2017)  Discovery of 2-((3-Acrylamido-4-methylphenyl)amino)-N-(2-methyl-5-(3,4,5-trimethoxybenzamido)phenyl)-4-(methylamino)pyrimidine-5-carboxamide (CHMFL-BMX-078) as a Highly Potent and Selective Type II Irreversible Bone Marrow Kinase in the X Chromosome (BMX) Kinase Inhibitor.,  60  (5): [PMID:28140585] [10.1021/acs.jmedchem.6b01413]

Source